Covering all the Bases: Preclinical Development of an Effective Staphylococcus aureus Vaccine
Open Access
- 24 March 2014
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 5, 109
Abstract
A key aspect of the pathogenesis of the Gram positive bacterium Staphylococcus aureus is its ability to rapidly adapt to the host environment during the course of an infection. To successfully establish infection, the organism deploys a variety of survival and immune evasion strategies, ranging from the acquisition of essential nutrients and expression of adhesins, which promote colonization and survival, to the elaboration of virulence factors such as capsule, which aids host immune evasion. The ability of S. aureus to deploy different virulence factors must be taken into account for S. aureus vaccine design. Here we present a strategy for designing an effective vaccine against S. aureus disease by evaluating vaccine candidate performance in multiple in vivo models targeted to mimic aspects of human disease, and by co-development of functional in vitro immunoassays that measure the neutralization of relevant S. aureus virulence factors.Keywords
This publication has 76 references indexed in Scilit:
- A Recombinant Clumping Factor A-Containing Vaccine Induces Functional Antibodies to Staphylococcus aureus That Are Not Observed after Natural ExposureClinical and Vaccine Immunology, 2012
- Staphylococcus aureus Manganese Transport Protein C Is a Highly Conserved Cell Surface Protein That Elicits Protective Immunity Against S. aureus and Staphylococcus epidermidisThe Journal of Infectious Diseases, 2012
- Neutrophils in innate host defense against Staphylococcus aureus infectionsSeminars in Immunopathology, 2011
- IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challengeVaccine, 2010
- Host Defense and Pathogenesis in Staphylococcus aureus InfectionsInfectious Disease Clinics of North America, 2009
- The Panton–Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300Clinical Microbiology and Infection, 2009
- Mutations in STAT3 and IL12RB1 impair the development of human IL-17–producing T cellsJournal of Experimental Medicine, 2008
- Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3 Journal of Experimental Medicine, 2008
- Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndromeNature, 2008
- Vaccine assembly from surface proteins ofStaphylococcus aureusProceedings of the National Academy of Sciences, 2006